BioAtla
phase cab summary of treatment emergent adverse events non squamous | BioAtla
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
37 of 55
Similar slides by BioAtla
See diffirences between slides (animation)
Investor Presentation
January 2024
phase cab treatment emergent adverse events non squamous | BioAtla
Related slides by other companies
AngloAmerican
Results
February 2024
safety at | AngloAmerican
Erasca
Investor Presentation
November 2023
phase patients continuing on treatment on potential for confirmation of dor and advantage in seacraft | Erasca
argenx SE
Results
May 2022
demonstrated favorable safety profile | argenx SE
Ocuphire Pharma
Results
October 2022
oral treatments in clinical development | Ocuphire Pharma
Other recent decks by BioAtla
See all presentations (8 decks)
Investor Presentation
August 2023
Investor Presentation
May 2023
Investor Presentation
November 2022
Investor Presentation
August 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io